E. DİRİCAN, "LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.21, pp.1-2, 2020
DİRİCAN, E. 2020. LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.21 , 1-2.
DİRİCAN, E., (2020). LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.21, 1-2.
DİRİCAN, EBUBEKİR. "LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.21, 1-2, 2020
DİRİCAN, EBUBEKİR. "LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.21, pp.1-2, 2020
DİRİCAN, E. (2020) . "LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.21, pp.1-2.
@article{article, author={EBUBEKİR DİRİCAN}, title={LETTER to the EDITOR: BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2020, pages={1-2} }